Taking 8000 Steps or More for 1-2 Days a Week Reduces the Risk of Mortality
Compared with participants who walked 8000 steps or more 0 days per week, all-cause mortality risk was lower among those who took 8000 steps or more 1 to 2 days per week (aRD, −14.9%; 95% CI) and 3 to 7 days per week (aRD, −16.5%; 95% CI). The protective association plateaued when individuals took sufficient daily steps for 3 days or more per week.
Dulaglutide Could be a Game Changer in Treating Type 2 Diabates and Obesity
Dulaglutide (Trulicity) is the newest edition to the GLP-1 RA family for the treatment of T2D. Studies have shown that dulaglutide is more effective than other antidiabetics in reducing HbA1c ≥1%. Dulaglutide has demonstrated weight loss of ∼ 6 pounds, which has been sustained over at least 26 weeks. Unlike other agents, dulaglutide is administered once-weekly at any time of the day.
World’s First Partial Heart Transplant Performed in an Infant
A child was born at Duke with truncus arteriosus, in which 2 main heart arteries were fused together. His one vessel had a leaky valve, making it less likely he could survive until a full heart transplant. So the doctors implanted the living arteries & valves from a donor heart into the patient’s existing heart. Valves will grow with the patient, reducing the need for multiple surgeries.
